14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $14.59 $16.25 Wednesday, 1st May 2024 CPRX stock ended at $15.20. This is 1.00% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 3.67% from a day low at $14.97 to a day high of $15.52.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
Jan 14, 2022 $6.09 $6.26 $5.97 $6.24 870 400
Jan 13, 2022 $6.28 $6.44 $6.11 $6.14 834 700
Jan 12, 2022 $6.43 $6.48 $6.21 $6.23 752 700
Jan 11, 2022 $6.37 $6.42 $6.21 $6.38 636 500
Jan 10, 2022 $6.51 $6.51 $6.24 $6.36 957 600
Jan 07, 2022 $6.60 $6.73 $6.49 $6.56 661 100
Jan 06, 2022 $6.51 $6.78 $6.50 $6.60 747 600
Jan 05, 2022 $6.89 $6.93 $6.49 $6.51 884 800
Jan 04, 2022 $6.94 $7.05 $6.72 $6.80 762 799
Jan 03, 2022 $6.79 $6.93 $6.72 $6.92 844 131
Dec 31, 2021 $6.99 $7.01 $6.75 $6.77 653 418
Dec 30, 2021 $7.16 $7.28 $6.87 $6.89 873 803
Dec 29, 2021 $7.05 $7.18 $7.02 $7.17 568 874
Dec 28, 2021 $7.23 $7.35 $7.06 $7.07 714 939
Dec 27, 2021 $7.22 $7.29 $7.13 $7.26 692 474
Dec 23, 2021 $6.99 $7.21 $6.93 $7.18 837 953
Dec 22, 2021 $6.92 $7.08 $6.83 $6.99 1 041 332
Dec 21, 2021 $7.05 $7.05 $6.80 $6.90 1 309 785
Dec 20, 2021 $6.89 $6.95 $6.63 $6.92 1 481 599
Dec 17, 2021 $6.70 $7.19 $6.70 $6.90 4 945 199
Dec 16, 2021 $6.93 $7.00 $6.66 $6.72 1 273 847
Dec 15, 2021 $6.50 $6.93 $6.40 $6.92 1 509 337
Dec 14, 2021 $6.50 $6.57 $6.33 $6.39 1 494 608
Dec 13, 2021 $6.64 $6.68 $6.49 $6.52 1 109 518
Dec 10, 2021 $6.64 $6.72 $6.51 $6.59 927 749
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT